CENPN and hepatocellular carcinoma: Our results show that interfering with CENPN expression in HCC can inhibit c-myc and cyclin E expression by activating the p27-CDK4/cyclin D1 and p21-CDK2/cyclin E axes, thus reducing the level of phosphorylated Rb and inhibiting E2F1 transcription.